0001209191-20-045101.txt : 20200805
0001209191-20-045101.hdr.sgml : 20200805
20200805162047
ACCESSION NUMBER: 0001209191-20-045101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 201077620
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2020-08-03
4
M
0
2330
86.52
A
29168
D
Common Stock
2020-08-03
4
S
0
500
276.98
D
28668
D
Common Stock
2020-08-03
4
S
0
1100
278.13
D
27568
D
Common Stock
2020-08-03
4
S
0
730
279.41
D
26838
D
Stock Option (Right to Buy)
86.52
2020-08-03
4
M
0
2330
0.00
D
2027-02-02
Common Stock
2330
4660
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $276.98 (range $276.60 to $277.39).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $278.13 (range $277.73 to $278.58).
Open market sales reported on this line occurred at a weighted average price of $279.41 (range $279.03 to $279.70).
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-08-05